Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Vaccine

• Publication date

  2012-08-31

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.vaccine.2012.07.032PMID 22835740
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of a candidate International Standard for Meningococcal Group C polysaccharide.

  2012cited by this paper
• Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans.

  2011cited by this paper
• Emergence of Epidemic Neisseria meningitidis Serogroup X Meningitis in Togo and Burkina Faso

  2011influential reference
• Quadrivalent meningococcal conjugate vaccines.

  2009cited by this paper
• The Polysialic Acid-specific O-Acetyltransferase OatC from Neisseria meningitidis Serogroup C Evolved Apart from Other Bacterial Sialate O-Acetyltransferases*♦

  2009cited by this paper
• Epidemiology and risk factors for serogroup X meningococcal meningitis during an outbreak in western Kenya, 2005-2006.

  2009cited by this paper
• Protective Meningococcal Capsular Polysaccharide Epitopes and the Role of O Acetylation

  2007cited by this paper
• Serogroup X in Meningococcal Disease, Western Kenya

  2007cited by this paper
• Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger.

  2007cited by this paper
• Comparison of three ELISA protocols to measure antibody responses elicited against serogroup C meningococcal polysaccharide in mouse, monkey and human sera.

  2006cited by this paper
• Full NMR assignment and revised structure for the capsular polysaccharide from Streptococcus pneumoniae type 15B.

  2005cited by this paper
• Serologic correlates of protection for evaluating the response to meningococcal vaccines

  2004cited by this paper
• Immunogenicity and bactericidal activity in mice of an outer membrane protein vesicle vaccine against Neisseria meningitidis serogroup A disease.

  2004cited by this paper
• Assignment of Neisseria meningitidis Serogroups A, C, W135, and Y Anticapsular Total Immunoglobulin G (IgG), IgG1, and IgG2 Concentrations to Reference Sera

  2004cited by this paper
• Chemical Structure, Conjugation, and Cross-Reactivity of Bacillus pumilus Sh18 Cell Wall Polysaccharide

  2004cited by this paper
• Solid supports in enzyme-linked immunosorbent assay and other solid-phase immunoassays.

  2004cited by this paper
• The Neisseria meningitidis Serogroup A Capsular Polysaccharide O-3 and O-4 Acetyltransferase*

  2004cited by this paper
• Validation of Serological Correlate of Protection for Meningococcal C Conjugate Vaccine by Using Efficacy Estimates from Postlicensure Surveillance in England

  2003cited by this paper
• Multi-locus sequence typing: a tool for global epidemiology.

  2003cited by this paper
• Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana.

  2002cited by this paper
• Effect of O Acetylation of Neisseria meningitidis Serogroup A Capsular Polysaccharide on Development of Functional Immune Responses

  2002cited by this paper
• O-Acetylation status of the capsular polysaccharides of serogroup Y and W135 meningococci isolated in the UK.

  2002cited by this paper
• Evaluation of meningococcal C oligosaccharide conjugate vaccines by size‐exclusion chromatography/multi‐angle laser light scattering

  2002cited by this paper
• Use and validation of NMR assays for the identity and O-acetyl content of capsular polysaccharides from Neisseria meningitidis used in vaccine manufacture.

  2002cited by this paper
• Purification of capsular polysaccharide.

  2001cited by this paper
• Evaluation of De-O-Acetylated Meningococcal C Polysaccharide-Tetanus Toxoid Conjugate Vaccine in Infancy: Reactogenicity, Immunogenicity, Immunologic Priming, and Bactericidal Activity against O-Acetylated and De-O-Acetylated Serogroup C Strains

  2001cited by this paper
• An NMR spectroscopic identity test for the control of the capsular polysaccharide from Haemophilus influenzae type b.

  2000cited by this paper
• Prevalence of de-O-acetylated serogroup C meningococci before the introduction of meningococcal serogroup C conjugate vaccines in the United Kingdom.

  2000cited by this paper
• Structure activity studies on group C meningococcal polysaccharide-protein conjugate vaccines: effect of O-acetylation on the nature of the protective epitope.

  2000cited by this paper
• Simultaneous determination of glucosamine and glucosamine 4-phosphate in Lipid A with high-performance anion-exchange chromatography (HPAEC).

  1998cited by this paper
• Persistence of antibodies to meningococcal IgA1 protease versus decay of antibodies to group A polysaccharide and Opc protein.

  1997cited by this paper
• Recent progress in carbohydrate separation by high-performance liquid chromatography based on hydrophilic interaction

  1996cited by this paper
• Protein Determination by UV Absorption

  1996cited by this paper
• Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay

  1994cited by this paper
• Involvement of phospholipid end groups of group C Neisseria meningitidis and Haemophilus influenzae type b polysaccharides in association with isolated outer membranes and in immunoassays

  1994cited by this paper
• Two enzyme linked immunosorbent assays for detecting antibodies against meningococcal capsular polysaccharides A and C.

  1994cited by this paper
• Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay

  1992cited by this paper
• Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccinees and carriers

  1991cited by this paper
• Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease.

  1991cited by this paper
• Comparisons of standard curve-fitting methods to quantitate Neisseria meningitidis group A polysaccharide antibody levels by enzyme-linked immunosorbent assay

  1991cited by this paper
• Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

  1990cited by this paper
• Covalently linked peptides for enzyme-linked immunosorbent assay.

  1990cited by this paper
• Spectrophotometry as a tool for assaying endotoxins.

  1977cited by this paper
• Studies on the group-specific polysaccharide of Neisseria meningitidis serogroup X and an improved procedure for its isolation.

  1974cited by this paper
• Determination of the structure and conformation of bacterial polysaccharides by carbon 13 nuclear magnetic resonance. Studies on the group-specific antigens of Neisseria meningitidis serogroups A and X.

  1974cited by this paper
• Quantitative determination of the human immune response to immunization with meningococcal vaccines.

  1972cited by this paper
• Isolation and Characterization of Neisseria meningitidis Groups A, C, X, and Y Polysaccharide Antigens

  1970cited by this paper
• HUMAN IMMUNITY TO THE MENINGOCOCCUS

  1969cited by this paper
• HUMAN IMMUNITY TO THE MENINGOCOCCUS

  1969cited by this paper
• HUMAN IMMUNITY TO THE MENINGOCOCCUS

  1969cited by this paper

• Recent advances on the syntheses of oligosaccharides and the corresponding glycoconjugates towards development of vaccine candidates against invasive Neisseria meningitidis strains.

  2025cites this paper
• Understanding meningococcal X unconjugated saccharide behaviour in monovalent and pentavalent (A, C, Y, W and X) conjugate formulations for quality analysis of meningococcal conjugate vaccine.

  2025cites this paper
• Acid hydrolysis conditions for quantification of meningococcal X polysaccharide in a pentavalent vaccine using HPAEC-PAD/ESI-MS.

  2023cites this paper
• Structural characterization of a nonhydrolyzing UDP-GlcNAc 2-epimerase from Neisseria meningitidis serogroup A.

  2020cites this paper
• Evaluation of impact of temperature and pH alterations on the size and antigenicity of meningococcal serogroup A and X polysaccharides and conjugates.

  2019cites this paper
• Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007.

  2018cites this paper
• Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development

  2018cites this paper
• Quality, immunogenicity and stability of meningococcal serogroup ACWY-CRM197, DT and TT glycoconjugate vaccines.

  2017cites this paper
• Evaluation of candidate international standards for meningococcal serogroups A and X polysaccharide.

  2017cites this paper
• Surveillance of Bacterial Meningitis, Ethiopia, 2012–2013

  2016cites this paper
• An efficient cell free enzyme-based total synthesis of a meningococcal vaccine candidate

  2016cites this paper
• Contribution of murine IgG Fc regions to antibody binding to the capsule of Burkholderia pseudomallei

  2016cites this paper
• Simple alternative to sialic acid determination in meningococcal polysaccharides W or Y.

  2016cites this paper
• Bacterial Polysaccharide Vaccines: Analytical Perspectives

  2015cites this paper
• Synthesis of a tetrasaccharide and its glycoconjugate corresponding to the capsular polysaccharide of Neisseria meningitidis serogroup X and its immunochemical studies

  2015cites this paper
• Characterization of Carbohydrate Vaccines by NMR Spectroscopy.

  2015cites this paper
• A novel monoclonal antibody to Neisseria meningitidis serogroup X capsular polysaccharide and its potential use in quantitation of meningococcal vaccines.

  2014cites this paper
• Development and Evaluation of a Dipstick Diagnostic Test for Neisseria meningitidis Serogroup X

  2014cites this paper
• Functional expression of the capsule polymerase of Neisseria meningitidis serogroup X: a new perspective for vaccine development.

  2014cites this paper
• Development and evaluation of a dipstick diagnostic test for Neisseria meningitidis 1 serogroup X 2 3

  2014cites this paper
• Process development and immunogenicity studies on a serogroup 'X' Meningococcal polysaccharide conjugate vaccine.

  2014cites this paper
• Serogroup C meningococcal conjugate vaccines: immunogenicity, immune persistence and induction of immunological memory

  2014influential citation
• Efficient Synthesis of Meningococcal X Polysaccharide Repeating Unit (N-Acetylglucosamine-4-phosphate) as Analytical Standard for Polysaccharide Determination

  2014cites this paper
• Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt.

  2014cites this paper
• Structure, biosynthesis, and function of bacterial capsular polysaccharides synthesized by ABC transporter-dependent pathways.

  2013cites this paper
• Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?

  2013cites this paper
• Structure and biosynthesis of capsular polysaccharides synthesized via ABC transporter-dependent processes

  2013cites this paper
• The Biology of Neisseria Adhesins

  2013cites this paper
• Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa

  2013cites this paper
• Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X

  2013cites this paper
• Glycoconjugate vaccines

  2013cites this paper
• Meningococcal X polysaccharide quantification by high-performance anion-exchange chromatography using synthetic N-acetylglucosamine-4-phosphate as standard.

  2013cites this paper
• Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.

  2013cites this paper
• Contribution of murine IgG Fc regions to antibody binding to the Contribution of murine IgG Fc regions to antibody binding to the capsule of capsule ofBurkholderia pseudomallei Burkholderia pseudomallei

  year unknowncites this paper